Floridienne (FLOB) investor relations material

Executive summary

• Turnover increased to EUR 348.3 million as at 30 June 2026, up 3.2% year-over-year, with all divisions contributing to growth despite a challenging macroeconomic environment.

• EBITDA rose 12.5% to EUR 40.5 million, driven by higher sales, cost control, and efficient production.

• Net result improved significantly to EUR 1.3 million from a loss of EUR 8.2 million in H1 2025.

• All divisions reported improved profitability, with notable recovery in the Recycling Division and record performance in BIOTROP.

• Positive outlook for the full year, with confidence in further improvement over 2025.

Financial highlights

• Consolidated turnover: EUR 348.3 million (+3.2% year-over-year).

• EBITDA: EUR 40.5 million (+12.5% year-over-year).

• Net result: EUR 1.3 million (vs. -EUR 8.2 million in H1 2025).

• Equity capital: EUR 677.8 million, up EUR 58.9 million since December 2025.

• Net financial debt: EUR 302.7 million, up from EUR 266.5 million at year-end 2025.

Outlook and guidance

• Board expects better results for 2026 compared to 2025, supported by strong H1 performance.

• Life Sciences Division anticipates continued growth, especially with BIOTROP's expansion in Europe and North America.

• Food Division expects profitability improvements to persist, especially during the holiday season.

• Recycling Division to benefit from new installations and regulatory tailwinds.

• External risks monitored include Middle East conflict, energy costs, interest rates, and potential El Niño impacts.